ES2169116T3 - Uso de los derivados de 2-amino purina en el tratamiento y profilaxis del virus 6 del herpes humano. - Google Patents

Uso de los derivados de 2-amino purina en el tratamiento y profilaxis del virus 6 del herpes humano.

Info

Publication number
ES2169116T3
ES2169116T3 ES95900126T ES95900126T ES2169116T3 ES 2169116 T3 ES2169116 T3 ES 2169116T3 ES 95900126 T ES95900126 T ES 95900126T ES 95900126 T ES95900126 T ES 95900126T ES 2169116 T3 ES2169116 T3 ES 2169116T3
Authority
ES
Spain
Prior art keywords
treatment
profilaxis
purina
virus
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95900126T
Other languages
English (en)
Inventor
Hodge Richard Anthony Smi Vere
Malcolm Richard Boyd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Novartis International Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis International Pharmaceutical Ltd filed Critical Novartis International Pharmaceutical Ltd
Application granted granted Critical
Publication of ES2169116T3 publication Critical patent/ES2169116T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Abstract

EL USO DE UN COMPUESTO DE LA FORMULA (A), O DE UN BIOPRECURSOR, O DE UNA SAL FARMACEUTICAMENTE ACEPTABLE, ESTER DE FOSFATO Y/O DERIVADO DE ACILO DE CUALQUIERA DE LOS ANTERIORES PARA LA FABRICACION DE UN MEDICAMENTO PARA EL TRATAMIENTO (INCLUIDA LA PROFILAXIS) DE UNA INFECCION PROVOCADA POR EL HHV-6.
ES95900126T 1993-11-12 1994-11-08 Uso de los derivados de 2-amino purina en el tratamiento y profilaxis del virus 6 del herpes humano. Expired - Lifetime ES2169116T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939323403A GB9323403D0 (en) 1993-11-12 1993-11-12 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ES2169116T3 true ES2169116T3 (es) 2002-07-01

Family

ID=10745091

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95900126T Expired - Lifetime ES2169116T3 (es) 1993-11-12 1994-11-08 Uso de los derivados de 2-amino purina en el tratamiento y profilaxis del virus 6 del herpes humano.

Country Status (18)

Country Link
US (1) US6057327A (es)
EP (1) EP0728001B1 (es)
JP (1) JP4453880B2 (es)
KR (1) KR100341737B1 (es)
CN (1) CN1074925C (es)
AT (1) ATE210985T1 (es)
AU (1) AU690159B2 (es)
CA (1) CA2176376C (es)
CY (1) CY2338B1 (es)
DE (1) DE69429538T2 (es)
DK (1) DK0728001T3 (es)
ES (1) ES2169116T3 (es)
GB (1) GB9323403D0 (es)
HK (1) HK1012233A1 (es)
PT (1) PT728001E (es)
SI (1) SI0728001T1 (es)
WO (1) WO1995013073A1 (es)
ZA (1) ZA948907B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110105434A1 (en) * 2007-11-21 2011-05-05 Exley Ray W 2-amino purine derivatives and their use as anti-herpetic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
EP0182024B1 (en) * 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
AU635642B2 (en) * 1990-05-24 1993-03-25 E.R. Squibb & Sons, Inc. Fluorinated bis(hydroxymethyl) cyclobutyl purines and pyrimidines
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment

Also Published As

Publication number Publication date
ATE210985T1 (de) 2002-01-15
PT728001E (pt) 2002-06-28
DE69429538T2 (de) 2002-07-25
KR100341737B1 (ko) 2002-11-25
CA2176376A1 (en) 1995-05-18
WO1995013073A1 (en) 1995-05-18
EP0728001B1 (en) 2001-12-19
CA2176376C (en) 2007-10-02
GB9323403D0 (en) 1994-01-05
AU690159B2 (en) 1998-04-23
JP4453880B2 (ja) 2010-04-21
US6057327A (en) 2000-05-02
EP0728001A1 (en) 1996-08-28
AU8106794A (en) 1995-05-29
CY2338B1 (en) 2004-02-06
ZA948907B (en) 1995-08-17
CN1074925C (zh) 2001-11-21
HK1012233A1 (en) 1999-07-30
CN1136276A (zh) 1996-11-20
DK0728001T3 (da) 2002-04-15
DE69429538D1 (de) 2002-01-31
JPH09511217A (ja) 1997-11-11
SI0728001T1 (en) 2002-04-30

Similar Documents

Publication Publication Date Title
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
LV10923A (lv) Penciklovira atvasinajumi hepatita-B infekciju arstesanai
ES2169117T3 (es) Uso de derivados de 2-aminopurina en el tratamiento y profilaxis de la infeccion por el virus 7 del herpes humano.
ES2169116T3 (es) Uso de los derivados de 2-amino purina en el tratamiento y profilaxis del virus 6 del herpes humano.
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
BR9607663A (pt) Uso de penciclovir para o tratamento de herpes-virus 8 humano
MX9704336A (es) Uso de agentes antivirales para el tratamiento y profilaxis de infecciones latentes de herpesvirus.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 728001

Country of ref document: ES